New diabetes clinical trial: A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

Published on: June 29, 2020 at 09:30PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: LY3209590;   Drug: Insulin Degludec
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/2Vt6awm